Innovent Biologics

1801.HK
Developing and commercializing high-quality biologic medicines.
Developing and commercializing high-quality biologic medicines.

F-Prime Team

Sector

Life Sciences

Category

Therapeutics

Location

Suzhou, China

Initial Investment

2011
Innovent Biologics

Innovent Biologics (1801.HK) has built a robust pipeline of innovative and commercially promising monoclonal antibodies and other biologics in the fields of oncology, ophthalmology, autoimmune, and cardiovascular diseases.